Mayo Clinic Proceedings Home

Effect of Center Volume on Outcomes in Hospitalized Patients With Hereditary Hemorrhagic Telangiectasia

Published:November 01, 2016DOI:



      To determine whether hospitalized patients with hereditary hemorrhagic telangiectasia (HHT) had better outcomes at high-volume treatment centers (HVCs).

      Patients and Methods

      The Nationwide Inpatient Sample (2000-2011) was used to identify HHT-related hospitalizations. Hospitals were classified based on quartiles of annual HHT discharge volume. The 75th percentile cutoff value (third quartile) was used to classify hospitals as low-volume centers (1-7 HHT discharges per year) or as HVCs (≥8 discharges per year. Demographic features, complication rates, and outcomes were compared between the 2 groups.


      We identified 9440 hospital discharges in patients with HHT. Of these patients, 6856 (72.6%) were admitted to low-volume centers and 2584 (27.4%) to HVCs. The former were more likely to be of white race, older, and with higher income levels (P<.001 for each). The HVCs had higher rates of anemia, epistaxis, congestive heart failure, pulmonary hypertension, and cerebral and pulmonary arteriovenous malformations and lower rates of ischemic stroke and myocardial infarction. After adjusting for baseline differences in a multivariate model, patients treated at HVCs were more likely to be discharged home (odds ratio [OR]=1.35; 95% CI, 1.21-1.52; P<.001) and less likely to be discharged to short-term rehabilitation facilities (OR=0.45; 95% CI, 0.31-0.64; P<.001). Patients treated at HVCs also had a significantly lower risk of in-hospital mortality (OR=0.51; 95% CI, 0.34-0.74; P<.001).


      Patients with HHT hospitalized at HVCs had better outcomes, with lower in-hospital mortality and higher home discharge rates. These findings strongly support ongoing efforts to expand access to HHT centers of excellence in the United States and worldwide.

      Abbreviations and Acronyms:

      AVM (arteriovenous malformation), CCI (Charlson comorbidity index), COE (center of excellence), HHT (hereditary hemorrhagic telangiectasia), HVC (high-volume center), IVC (inferior vena cava), LOS (length of stay), LVC (low-volume center), NIS (Nationwide Inpatient Sample), OR (odds ratio)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Mayo Clinic Proceedings
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Shovlin C.L.
        • Guttmacher A.E.
        • Buscarini E.
        • et al.
        Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome).
        Am J Med Genet. 2000; 91: 66-67
        • Pierucci P.
        • Lenato G.M.
        • Suppressa P.
        • et al.
        A long diagnostic delay in patients with Hereditary Haemorrhagic Telangiectasia: a questionnaire-based retrospective study.
        Orphanet J Rare Dis. 2012; 7: 33
        • Latino G.A.
        • Brown D.
        • Glazier R.H.
        • Weyman J.T.
        • Faughnan M.E.
        Targeting under-diagnosis in hereditary hemorrhagic telangiectasia: a model approach for rare diseases?.
        Orphanet J Rare Dis. 2014; 9: 115
        • Dospinescu C.
        • Simpson A.
        • Leslie S.J.
        Myocardial infarction in a patient with hereditary haemorrhagic telangiectasia in a remote location.
        Rural Remote Health. 2015; 15: 3169
        • Badheka A.O.
        • Singh V.
        • Patel N.J.
        • et al.
        Trends of hospitalizations in the United States from 2000 to 2012 of patients >60 years with aortic valve disease.
        Am J Cardiol. 2015; 116: 132-141
        • Charlson M.
        • Szatrowski T.P.
        • Peterson J.
        • Gold J.
        Validation of a combined comorbidity index.
        J Clin Epidemiol. 1994; 47: 1245-1251
        • Ouyang D.
        • El-Sayed I.H.
        • Yom S.S.
        National trends in surgery for sinonasal malignancy and the effect of hospital volume on short-term outcomes.
        Laryngoscope. 2014; 124: 1609-1614
        • Loyo M.
        • Tufano R.P.
        • Gourin C.G.
        National trends in thyroid surgery and the effect of volume on short-term outcomes.
        Laryngoscope. 2013; 123: 2056-2063
        • Sharma M.
        • Ambekar S.
        • Guthikonda B.
        • Wilden J.
        • Nanda A.
        Regional trends and the impact of various patient and hospital factors on outcomes and costs of hospitalization between academic and nonacademic centers after deep brain stimulation surgery for Parkinson's disease: a United States Nationwide Inpatient Sample analysis from 2006 to 2010.
        Neurosurg Focus. 2013; 35: E2
        • Arora S.
        • Panaich S.S.
        • Patel N.
        • et al.
        Impact of hospital volume on outcomes of lower extremity endovascular interventions (insights from the Nationwide Inpatient Sample [2006 to 2011]).
        Am J Cardiol. 2015; 116: 791-800
        • Shah N.
        • Chothani A.
        • Agarwal V.
        • et al.
        Impact of annual hospital volume on outcomes after left ventricular assist device (LVAD) implantation in the contemporary era.
        J Card Fail. 2016; 22: 232-237
        • Badheka A.O.
        • Patel N.J.
        • Panaich S.S.
        • et al.
        Effect of hospital volume on outcomes of transcatheter aortic valve implantation.
        Am J Cardiol. 2015; 116: 587-594
        • Bhatt P.
        • Patel N.J.
        • Patel A.
        • et al.
        Impact of hospital volume on outcomes of endovascular stenting for adult aortic coarctation.
        Am J Cardiol. 2015; 116: 1418-1424
        • Brinjikji W.
        • Lanzino G.
        • Cloft H.J.
        Cerebrovascular complications and utilization of endovascular techniques following transsphenoidal resection of pituitary adenomas: a study of the Nationwide Inpatient Sample 2001-2010.
        Pituitary. 2014; 17: 430-435
        • Leake C.B.
        • Brinjikji W.
        • Kallmes D.F.
        • Cloft H.J.
        Increasing treatment of ruptured cerebral aneurysms at high-volume centers in the United States.
        J Neurosurg. 2011; 115: 1179-1183
        • Brinjikji W.
        • Kallmes D.F.
        • Lanzino G.
        • Cloft H.J.
        Carotid revascularization treatment is shifting to low volume centers.
        J Neurointerv Surg. 2015; 7: 336-340
        • Amato L.
        • Colais P.
        • Davoli M.
        • et al.
        Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data.
        Epidemiol Prev. 2013; 37 ([in Italian]): 1-100
        • Weiss E.S.
        • Meguid R.A.
        • Patel N.D.
        • et al.
        Increased mortality at low-volume orthotopic heart transplantation centers: should current standards change?.
        Ann Thorac Surg. 2008; 86 (discussion 1259-1260): 1250-1259
        • Weiss E.S.
        • Allen J.G.
        • Meguid R.A.
        • et al.
        The impact of center volume on survival in lung transplantation: an analysis of more than 10,000 cases.
        Ann Thorac Surg. 2009; 88: 1062-1070
        • Pallin D.J.
        • Espinola J.A.
        • Camargo Jr., C.A.
        US population aging and demand for inpatient services.
        J Hosp Med. 2014; 9: 193-196
        • Donaldson J.W.
        • McKeever T.M.
        • Hall I.P.
        • Hubbard R.B.
        • Fogarty A.W.
        The UK prevalence of hereditary haemorrhagic telangiectasia and its association with sex, socioeconomic status and region of residence: a population-based study.
        Thorax. 2014; 69: 161-167
        • Plauchu H.
        • de Chadarevian J.P.
        • Bideau A.
        • Robert J.M.
        Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population.
        Am J Med Genet. 1989; 32: 291-297
        • Faughnan M.E.
        • Palda V.A.
        • Garcia-Tsao G.
        • et al.
        International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia.
        J Med Genet. 2011; 48: 73-87
        • Grosse S.D.
        • Boulet S.L.
        • Grant A.M.
        • Hulihan M.M.
        • Faughnan M.E.
        The use of US health insurance data for surveillance of rare disorders: hereditary hemorrhagic telangiectasia.
        Genet Med. 2014; 16: 33-39

      Linked Article

      • Correction
        Mayo Clinic ProceedingsVol. 92Issue 2
        • Preview
          In the article titled, “Effect of Center Volume on Outcomes in Hospitalized Patients With Hereditary Hemorrhagic Telangiectasia,” published in the December 2016 issue of Mayo Clinic Proceedings (Mayo Clin Proc. 2016;91(12):1753-1760), there is an error in Table 2. The number for high-volume centers for coronary artery disease should be 416, not 1416.
        • Full-Text
        • PDF